Why do my muscles hurt on cholesterol medication?

Muscle pain from cholesterol medications (statins) affects 10-25% of users and occurs because statins can reduce CoQ10 production and disrupt muscle cell energy. Most cases are mild and manageable through dose adjustments, switching medications, or supplementation.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Statin-Related Muscle Pain

If you're experiencing muscle pain while taking cholesterol medication, you're not alone. Studies show that between 10% and 25% of people taking statins report muscle-related side effects, making it one of the most common reasons patients discontinue their medication. This pain, known medically as statin-associated muscle symptoms (SAMS), can range from mild discomfort to severe weakness that interferes with daily activities.

Statins work by blocking an enzyme called HMG-CoA reductase, which your liver uses to produce cholesterol. While this effectively lowers your LDL cholesterol and reduces cardiovascular risk, the same mechanism can affect muscle cells throughout your body. Understanding why this happens and how to manage it can help you maintain your heart health without compromising your quality of life.

The Science Behind Statin-Induced Muscle Pain

CoQ10 Depletion

One of the primary culprits behind statin-related muscle pain is the depletion of Coenzyme Q10 (CoQ10). When statins block cholesterol production, they also interfere with the production of CoQ10, a vital compound that helps generate energy in your cells' mitochondria. Muscle cells are particularly energy-demanding, so when CoQ10 levels drop, they're often the first to show signs of dysfunction.

Statin-Related Muscle Symptom Severity Levels

CK = Creatine Kinase; ULN = Upper Limit of Normal. Severity assessment should always include clinical evaluation beyond laboratory values.
Severity LevelSymptomsCK LevelsFrequencyTypical Action
MyalgiaMyalgiaMuscle pain, tenderness, weaknessNormal10-15% of usersContinue statin, consider dose adjustment
Mild MyopathyMild MyopathyMuscle weakness, mild pain< 4x ULN1-5% of usersMonitor closely, may adjust dose
MyositisMyositisMuscle weakness with inflammation4-10x ULN< 1% of usersUsually discontinue statin
Severe MyopathySevere MyopathySignificant weakness, pain> 10x ULN< 0.1% of usersDiscontinue immediately
RhabdomyolysisRhabdomyolysisSevere pain, dark urine, kidney risk> 40x ULN1 in 100,000Medical emergency

CK = Creatine Kinase; ULN = Upper Limit of Normal. Severity assessment should always include clinical evaluation beyond laboratory values.

Research indicates that statin use can reduce CoQ10 levels by up to 40%. This reduction affects the electron transport chain in mitochondria, leading to decreased ATP production and increased oxidative stress in muscle tissue. The result is muscle fatigue, pain, and in some cases, actual muscle damage.

Genetic Factors

Your genetic makeup plays a significant role in determining whether you'll experience muscle pain from statins. Variations in the SLCO1B1 gene, which affects how your body processes statins, can increase your risk of muscle symptoms by up to five times. Additionally, variations in genes like CYP3A4 and ABCB1 can affect statin metabolism and transport, influencing both effectiveness and side effect risk.

Muscle Cell Membrane Disruption

Statins may also directly affect muscle cell membranes by altering their cholesterol content. Since cholesterol is a crucial component of cell membranes, reduced cholesterol synthesis can make muscle cell membranes less stable and more prone to injury during normal use or exercise.

Types and Severity of Muscle Symptoms

Statin-related muscle symptoms exist on a spectrum, and understanding where your symptoms fall can help guide treatment decisions. The severity and type of symptoms you experience can vary based on the specific statin, dosage, and individual factors.

Myalgia

The most common form of statin-related muscle symptoms is myalgia, affecting approximately 10-15% of statin users. This involves muscle pain, tenderness, or weakness without elevation in creatine kinase (CK) levels. Symptoms typically affect large muscle groups like the thighs, shoulders, and back, and may worsen with exercise.

Myopathy and Myositis

More severe but less common, myopathy involves muscle weakness with CK levels elevated up to 10 times the upper limit of normal. Myositis includes both muscle weakness and inflammation. These conditions affect fewer than 1% of statin users but require immediate medical attention and typically necessitate discontinuing the medication.

Rhabdomyolysis

The most severe form of statin-related muscle damage, rhabdomyolysis, is extremely rare, occurring in approximately 1 in 100,000 statin users. This condition involves severe muscle breakdown that can lead to kidney failure. Symptoms include severe muscle pain, dark urine, and extreme weakness. This is a medical emergency requiring immediate hospitalization.

Risk Factors for Developing Muscle Pain

Several factors can increase your likelihood of experiencing muscle pain while taking statins. Understanding these risk factors can help you and your healthcare provider make informed decisions about your treatment plan.

  • Age over 65 years
  • Female gender
  • Low body mass index or frailty
  • Kidney or liver disease
  • Hypothyroidism
  • Vitamin D deficiency
  • Excessive alcohol consumption
  • Intense physical activity
  • Taking multiple medications that interact with statins
  • Previous history of muscle disorders
  • Asian ancestry (may require lower doses)

If you have multiple risk factors, your healthcare provider might recommend starting with a lower dose, choosing a different statin, or monitoring you more closely for side effects. Regular blood testing can help identify issues early, including checking CK levels, liver enzymes, and thyroid function.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnostic Approaches and Testing

Properly diagnosing statin-related muscle symptoms requires a systematic approach. Your healthcare provider will typically start with a detailed history of your symptoms, including when they started relative to beginning statin therapy, which muscles are affected, and whether symptoms improve when you miss doses.

Laboratory Testing

Key laboratory tests for evaluating muscle symptoms include:

  • Creatine Kinase (CK): Elevated levels indicate muscle damage
  • Thyroid function tests (TSH, Free T4): Hypothyroidism can worsen muscle symptoms
  • Vitamin D levels: Deficiency increases risk of muscle pain
  • Liver function tests: Impaired liver function affects statin metabolism
  • Kidney function tests: Reduced kidney function increases statin levels
  • Complete blood count: Rules out other causes of fatigue and weakness

The Statin Challenge-Dechallenge-Rechallenge Protocol

To confirm whether your muscle symptoms are truly statin-related, your doctor might recommend a structured approach: stopping the statin for 2-4 weeks to see if symptoms resolve (dechallenge), then restarting it to see if symptoms return (rechallenge). This process can be repeated with different statins or doses to find a tolerable option.

Management Strategies for Muscle Pain

If you're experiencing muscle pain from statins, several evidence-based strategies can help manage your symptoms while maintaining cardiovascular protection. The approach depends on symptom severity and your cardiovascular risk level.

Medication Adjustments

Your healthcare provider might recommend several medication-related strategies:

  • Switching to a different statin (pravastatin and fluvastatin may have lower muscle symptom rates)
  • Reducing the dose
  • Trying alternate-day dosing with longer-acting statins like atorvastatin or rosuvastatin
  • Taking a drug holiday followed by rechallenge
  • Switching to non-statin cholesterol medications like ezetimibe or PCSK9 inhibitors

Supplementation Strategies

Several supplements have shown promise in reducing statin-related muscle symptoms:

  • CoQ10 (100-200 mg daily): May help restore depleted levels
  • Vitamin D (if deficient): Correcting deficiency can reduce muscle pain
  • Magnesium: Supports muscle function and may reduce cramping
  • L-carnitine: Some evidence for reducing muscle symptoms
  • Omega-3 fatty acids: May have protective effects on muscle tissue

Lifestyle Modifications

Certain lifestyle changes can help minimize muscle symptoms while supporting overall cardiovascular health:

  • Start exercise gradually and avoid sudden intense workouts
  • Stay well-hydrated, especially during physical activity
  • Maintain adequate protein intake to support muscle health
  • Limit alcohol consumption
  • Ensure adequate sleep for muscle recovery
  • Consider gentle stretching or yoga for muscle flexibility
  • Apply heat or cold therapy for symptom relief

Alternative Cholesterol-Lowering Options

For patients who cannot tolerate statins despite multiple attempts, several alternative medications can help manage cholesterol levels:

Non-Statin Medications

  • Ezetimibe: Reduces cholesterol absorption in the intestines
  • PCSK9 inhibitors (evolocumab, alirocumab): Injectable medications that dramatically lower LDL
  • Bempedoic acid: Oral medication that works upstream of statins
  • Bile acid sequestrants: Bind cholesterol in the digestive system
  • Fibrates: Primarily lower triglycerides but have modest LDL effects
  • Niacin: Though less commonly used due to side effects

Natural Approaches

While not as potent as medications, certain natural approaches can support cholesterol management:

  • Plant sterols and stanols (2-3 grams daily)
  • Soluble fiber from oats, beans, and psyllium
  • Red yeast rice (contains natural statins, may cause similar side effects)
  • Garlic supplements
  • Green tea catechins
  • Mediterranean or plant-based diet patterns

Monitoring Your Progress

Regular monitoring is essential when managing statin-related muscle symptoms. This includes tracking both your symptoms and your cardiovascular risk markers. Keep a symptom diary noting pain location, severity, timing, and any factors that improve or worsen symptoms.

Blood testing should include periodic checks of your lipid panel to ensure your cholesterol remains controlled, along with CK levels if you're experiencing significant muscle symptoms. Additional markers like apolipoprotein B (ApoB) can provide more detailed insight into your cardiovascular risk beyond standard cholesterol tests. Regular comprehensive testing helps ensure you're achieving cardiovascular protection while minimizing side effects.

When Muscle Pain Requires Immediate Attention

While most statin-related muscle pain is manageable, certain symptoms require immediate medical attention:

  • Severe muscle pain that develops suddenly
  • Dark, cola-colored urine (sign of rhabdomyolysis)
  • Extreme muscle weakness affecting daily activities
  • Muscle pain accompanied by fever or feeling generally unwell
  • Significant swelling in affected muscles
  • Inability to move certain muscle groups

These symptoms could indicate serious muscle damage requiring immediate treatment and discontinuation of the statin.

Making Informed Decisions About Your Treatment

Managing cholesterol while dealing with muscle pain requires balancing cardiovascular benefits against quality of life impacts. For most people, the cardiovascular benefits of statins outweigh the risks, but this calculation is individual. Work closely with your healthcare provider to find an approach that works for you.

Remember that muscle symptoms don't mean you have to abandon cholesterol management entirely. With patience and systematic approaches, most people can find a tolerable regimen that protects their heart health. Whether through dose adjustments, medication switches, supplements, or alternative therapies, there are multiple paths to achieving your cholesterol goals while maintaining your comfort and mobility.

If you're experiencing muscle pain on cholesterol medication, don't suffer in silence or stop your medication without consulting your healthcare provider. Open communication about your symptoms, combined with appropriate testing and a willingness to try different approaches, can lead to a solution that works for your unique situation. Your heart health is too important to leave unprotected, but neither should you have to endure debilitating side effects when alternatives exist.

References

  1. Stroes ES, Thompson PD, Corsini A, et al. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. European Heart Journal. 2015;36(17):1012-1022.[Link][PubMed][DOI]
  2. Ward NC, Watts GF, Eckel RH. Statin Toxicity: Mechanistic Insights and Clinical Implications. Circulation Research. 2019;124(2):328-350.[Link][PubMed][DOI]
  3. Rosenson RS, Baker S, Banach M, et al. Optimizing Cholesterol Treatment in Patients With Muscle Complaints. Journal of the American College of Cardiology. 2017;70(10):1290-1301.[Link][PubMed][DOI]
  4. Qu H, Guo M, Chai H, Wang WT, Gao ZY, Shi DZ. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association. 2018;7(19):e009835.[Link][PubMed][DOI]
  5. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal. 2020;41(1):111-188.[Link][PubMed][DOI]
  6. Newman CB, Preiss D, Tobert JA, et al. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology. 2019;39(2):e38-e81.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my cholesterol and muscle health markers at home?

You can test your cholesterol and related cardiovascular markers at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive lipid testing, inflammation markers, and metabolic health indicators. This CLIA-certified program provides lab-quality results from the comfort of your home.

What percentage of people experience muscle pain from statins?

Studies show that 10-25% of people taking statins report muscle-related side effects. However, severe muscle damage is rare, occurring in less than 1% of users. Most people experience mild to moderate symptoms that can be managed through dose adjustments or switching medications.

Can I stop taking my statin if I have muscle pain?

Never stop taking your statin without consulting your healthcare provider first. Abruptly stopping can increase your cardiovascular risk. Your doctor can help you safely adjust your dose, switch medications, or try alternative approaches while maintaining heart protection.

Does CoQ10 supplementation really help with statin muscle pain?

Research on CoQ10 for statin muscle pain shows mixed results, but many studies suggest benefits. Since statins can reduce CoQ10 levels by up to 40%, supplementation with 100-200 mg daily may help some people, though individual responses vary.

Are certain statins less likely to cause muscle pain?

Yes, pravastatin and fluvastatin tend to have lower rates of muscle symptoms compared to other statins. Hydrophilic statins like pravastatin may be less likely to penetrate muscle tissue. Your doctor can help determine which statin might work best for you.

How long after starting a statin do muscle symptoms typically appear?

Muscle symptoms can appear within weeks to months of starting statin therapy, though some people don't experience symptoms until they've been on the medication for years. Most symptoms appear within the first 6 months of treatment.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details